FDA Import Refusal SCS-2640932-7/11/1 — Glaxosmithkline
The FDA refused shipment SCS-2640932-7/11/1 from Glaxosmithkline (Canada) on Jan 23, 2019. The refused product falls under Drugs and Biologics — XYLOMETAZOLINE HCL (ADRENERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 23, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 60CAY53 XYLOMETAZOLINE HCL (ADRENERGIC)
- Charges
- 75